Results 201 to 210 of about 615,016 (327)

Toward a Universal Czochralski Growth Model Leveraging Data‐Driven Techniques

open access: yesAdvanced Theory and Simulations, EarlyView.
This data‐driven study investigates Czochralski growth using Decision Trees, Symbolic Regression, ANN, and SHAP to assess the impact of 21 process and design parameters on crystal quality. Trained on 632 CFD simulation datasets across four crystalline materials, it demonstrates the feasibility of a universal Cz model applicable to various ...
Natasha Dropka   +4 more
wiley   +1 more source

Advanced Microfluidics for Single Cell‐Based Cancer Research

open access: yesAdvanced Science, EarlyView.
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro   +10 more
wiley   +1 more source

Hayabusa2 extended mission target asteroid 1998 KY<sub>26</sub> is smaller and rotating faster than previously known. [PDF]

open access: yesNat Commun
Santana-Ros T   +18 more
europepmc   +1 more source

Electragel for Advanced Static Charge Mitigation and Energy Harvesting

open access: yesAdvanced Science, EarlyView.
Electragel is a transformative material that scavenges static charges for simultaneous dissipation and electricity generation, enabling dual‐purpose static control and energy harvesting across industries while shifting paradigms from mitigation to sustainable utilization of electrostatic energy. Abstract The heightened sensitivity of modern electronics
Irum Firdous   +5 more
wiley   +1 more source

TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition

open access: yesAdvanced Science, EarlyView.
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Yanchen Zhang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy